Hubert Schoemaker

From Wikipedia, the free encyclopedia

Hubert J. P. Schoemaker (born March 23, 1950 in Deventer, Netherlands – died January 1, 2006 in Paoli, Pennsylvania) was a Dutch-American chemist and biotechnological pioneer. Schoemaker was a co-founder and the president of the Bio-tech company Centocor. He helped develop Remicade, a drug to treat auto-immune disorders like Crohn's disease and rheumatoid arthritis. After selling Centocor to Johnson and Johnson for $5.2 billion in 1999, Schoemaker went on to form Neuronyx, Inc., a biotech company focused on developing cellular therapies. As of 2007, Neuronyx is in clinical trials testing adult bone marrow-derived cells in heart attack patients.


Persondata
NAME Schoemaker, Hubert
ALTERNATIVE NAMES
SHORT DESCRIPTION chemist and bio-tech expert
DATE OF BIRTH March 23, 1950
PLACE OF BIRTH Deventer, Netherlands
DATE OF DEATH January 1, 2006
PLACE OF DEATH Paoli, Pennsylvania
 This biographical article related to medicine in the United States is a stub. You can help Wikipedia by expanding it.
This biographical article about a chemist is a stub. You can help Wikipedia by expanding it.
Rachel Carson This article about a biologist from the United States is a stub. You can help Wikipedia by expanding it.
Languages